Lanceljx
12-17

The current pullback in U.S. equities reflects a rotation rather than a broad risk-off event.


The underperformance of the Nasdaq signals valuation sensitivity within AI-linked names, especially those that have rallied aggressively on forward-looking narratives. Broadcom and Oracle are being repriced not on earnings failure, but on expectations discipline. Markets are reassessing capex intensity, margin visibility, and the timing of AI monetisation rather than abandoning the theme outright.


Broadcom’s three-day decline, its sharpest since 2020, highlights how crowded positioning and elevated expectations can amplify downside when guidance lacks incremental upside. Oracle’s weakness reinforces similar concerns around cash flow strain and execution risk amid heavy investment cycles.


Importantly, this does not resemble a systemic tech unwind. Defensive sectors are holding, financial conditions remain orderly, and there is no sign of forced deleveraging. Instead, capital appears to be rotating toward quality, profitability, and near-term cash generation.


In the near term, AI stocks are likely to remain volatile, with selective consolidation rather than a trend reversal. The key question is not whether AI demand exists, but who can convert it into sustainable margins without overextending balance sheets. That distinction will increasingly drive performance.

# Record Options Expiry Meets BoJ: Can S&P 500 Close Higher Tonight?

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（2）

  • Top
  • Latest
  • Venus Reade
    ·12-19 19:15
    I’m really hoping AVGO fill 302 gap tomorrow. 300 is also 200 DMA so it should bounce of that. That gap fill and a 200 DMA test will be healthy for the stock… buyers will finally start showing up

    Reply
    Report
  • Valerie Archibald
    ·12-19 19:13
    Wonderful opportunity! AVGO will soar again.

    Reply
    Report